R Bellino
About
In The Last Decade
R Bellino
24 papers receiving 374 citations
Peers
Comparison fields: 5 of 70
- Oncology 98
- Cancer Research 84
- Molecular Biology 80
- Genetics 73
- Pathology and Forensic Medicine 65
Countries citing papers authored by R Bellino
This map shows the geographic impact of R Bellino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Bellino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Bellino more than expected).
Fields of papers citing papers by R Bellino
This network shows the impact of papers produced by R Bellino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Bellino. The network helps show where R Bellino may publish in the future.
Co-authorship network of co-authors of R Bellino
This figure shows the co-authorship network connecting the top 25 collaborators of R Bellino. A scholar is included among the top collaborators of R Bellino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Bellino. R Bellino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 12 | |
| 2 | 19 | |
| 3 | [Evaluation of myopia in a group of people working with video terminals: first results]. | 3 |
| 4 | 8 | |
| 5 | [Biologic therapy and epithelial ovarian cancer]. | 1 |
| 6 | Metaplastic breast carcinoma: pathology and clinical outcome. | 44 |
| 7 | The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosis. | 131 |
| 8 | Pathologic features of endometrial carcinoma in elderly women. | 5 |
| 9 | Capecitabine in association with epirubicin and docetaxel as a first line treatment in advanced breast cancer a multicenter phase II study | 5 |
| 10 | 66 | |
| 11 | Endometrial carcinoma in women 45 years of age or younger. | 7 |
| 12 | Reduced IL-2 level concentration in patients with breast cancer as a possible risk factor for relapse. | 18 |
| 13 | Two cases of ovarian cysts in postmenopausal patients under antiestrogen treatment. | 4 |
| 14 | Leiomyomas in patients receiving Tamoxifen. | 12 |
| 15 | 2 | |
| 16 | Lymph nodal metastases and pathological patterns in cervical cancer: a critical review. | 2 |
| 17 | Treatment failure in cervical cancer: high risk factors of relapse. | 4 |
| 18 | The place of pelvic exenteration in surgical management of advanced and recurrent pelvic tumors. | 1 |
| 19 | Techniques of pelvic and para-aortic lymphadenectomy in the surgical treatment of cervix carcinoma. | 17 |
| 20 | 3 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.